CLDX Competitors & Alternatives
Compare Celldex Therapeutics Inc with similar stocks in the same industry
Biotechnology
CLDX
Main Stock$29.35
Tradestie Score
54
Market Cap
$1.68B
Revenue Growth
-1.0%
Analyst Upside
+99.1%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$136.62
|
$2.41B | - | 52 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$27.60
|
$2.40B | - | 48 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$23.23
|
$2.37B | - | 66 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$82.72
|
$2.35B | - | 60 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$6.98
|
$2.34B | - | 53 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$67.25
|
$2.33B | - | 51 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$28.88
|
$2.33B | - | 55 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.04
|
$2.23B | - | 51 | Compare |
More CLDX Analysis
Data updated: Jun 11, 2026 | Industry: Biotechnology (SIC 2835)
220 stocks in this industry